Bio-Techne Corporation (TECH) Shareholders & Insider Trades
Bio-Techne shareholders at a glance
The largest holder of Bio-Techne stock is Fidelity Management & Research Co. LLC, with 12.5 million shares (7.99% of the company), worth about $906.00 million as of September 25, 2026. The 10 largest holders together own 49.7%.
In Q2 2026, 621 institutional holdings reports listed shares worth $12.50 billion.
Insiders reported 45 transactions in the last two years: 5 sales worth $3.14 million and no purchases. The newest one on file is from November 3, 2025 (Hippel James, Chief Financial Officer).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through November 3, 2025.
Bio-Techne Corporation
Shareholders Summary
2026Q2
Ownership by Type
Geographic Distribution
Largest Bio-Techne shareholders
| Holder | Shares | % of company | Value |
|---|---|---|---|
| Fidelity Management & Research Co. LLC | 12.5 million | 7.99% | $906.0M |
| BlackRock Advisors LLC | 11.8 million | 7.52% | $853.0M |
| Vanguard Capital Management LLC | 10.2 million | 6.52% | $739.0M |
| Goldman Sachs Asset Management LP | 7.3 million | 4.68% | $531.0M |
| HBK Investments LP | 6.8 million | 4.35% | $494.0M |
| Vanguard Portfolio Management LLC | 6.5 million | 4.15% | $470.0M |
| Eaton Vance Management | 6.4 million | 4.07% | $461.0M |
| State Street Corporation | 6.0 million | 3.81% | $432.0M |
| Geode Capital Management LLC | 5.4 million | 3.41% | $387.0M |
| Invesco Advisers, Inc. | 5.0 million | 3.18% | $361.0M |
As of September 25, 2026.
Bio-Techne institutional holdings by quarter
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 621 | – | $12.5B |
| Q1 2026 | 610 | – | $9.3B |
| Q4 2025 | 619 | – | $10.1B |
| Q3 2025 | 605 | 160.0 million | $8.9B |
| Q2 2025 | 576 | 159.0 million | $8.2B |
| Q1 2025 | 593 | 163.0 million | $9.6B |
| Q4 2024 | 597 | 162.0 million | $11.7B |
| Q3 2024 | 589 | 156.0 million | $12.4B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
Bio-Techne insider trades
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Hippel James | Nov 3, 2025 | Chief Financial Officer | -- | – |
| Geist William | Nov 3, 2025 | Officer | -- | – |
| Bushman Julie L. | Oct 30, 2025 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Vessey Rupert J | Oct 30, 2025 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Seth Alpna | Oct 30, 2025 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Klimovsky Judith V | Oct 30, 2025 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Herr Amy E. | Oct 30, 2025 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Higgins John L | Oct 30, 2025 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Keegan Joseph D | Oct 30, 2025 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Baumgartner Robert V | Oct 30, 2025 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Baumgartner Robert V | Aug 25, 2025 | Director | Sale at price 56.21 per share. | $957,818 |
| Nusse Roeland | Aug 25, 2025 | Director | Sale at price 56.36 per share. | $960,388 |
Newest 12 of 45 insider transactions in the last two years.
Questions and answers
Who owns the most Bio-Techne stock?
Fidelity Management & Research Co. LLC, with 7.99% of the company (as of September 25, 2026). Next: BlackRock Advisors LLC (7.52%) and Vanguard Capital Management LLC (6.52%).
How many institutions own Bio-Techne stock?
621 institutional holdings reports listed Bio-Techne shares in Q2 2026 worth $12.50 billion.
Are Bio-Techne insiders buying or selling the stock?
In the last two years insiders reported 5 sales and no purchases (45 transactions in all); the newest on file is from November 3, 2025.
